Prior, J. C., Klauss, V. S., Kalyan, S., & Pride, S. (2007). Effectiveness of ERr 731 in the management of symptomatic perimenopause: clinical significance. *Menopause (New York, N.Y.)*, *14*(2), 335-6; author reply 336-8. https://doi.org/10.1097/GME.0b013e318032aaa9
Prior JC, Klauss VS, Kalyan S, Pride S. Effectiveness of ERr 731 in the management of symptomatic perimenopause: clinical significance. Menopause. 2007;14(2):335-6; author reply 336-8. doi:10.1097/GME.0b013e318032aaa9
Prior, J. C., et al. "Effectiveness of ERr 731 in the management of symptomatic perimenopause: clinical significance." *Menopause (New York, N.Y.)*, vol. 14, no. 2, 2007, pp. 335-6; author reply 336-8.
Hitchcock CL et al., 2012Menopause (New York, N.Y.)
Objective: The aim of this study was to evaluate the associations between vasomotor symptoms ([VMS] hot flushes or flashes and night sweats) and markers of cardiovascular risk.
Methods: Healthy postme...
Hitchcock CL et al., 2012Menopause (New York, N.Y.)
Objective: The aim of this study was to compare oral micronized progesterone (progesterone) with placebo as therapy for postmenopausal hot flushes and night sweats (vasomotor symptoms [VMS]).
Methods:...
Prior JC et al., 2023
Open Access
Scientific Reports
This study tested progesterone for perimenopausal hot flush ± night sweat (vasomotor symptom, VMS) treatment. It was a double-blind, randomized trial of 300 mg oral micronized progesterone@bedtime ver...